[at noodls] – CAMBRIDGE, Mass., April 16, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]
[at noodls] – CAMBRIDGE, Mass., April 3, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]
[at noodls] – Promising Early Progress in Commercial Launch of JUXTAPID(TM) (lomitapide) Capsules CAMBRIDGE, Mass., March 6, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]
[at noodls] – CAMBRIDGE, Mass., March 5, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]
[at noodls] – CAMBRIDGE, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc.(Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]
[at noodls] – CAMBRIDGE, Mass., Feb. 20, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]
[at noodls] – CAMBRIDGE, Mass., Jan. 11, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) (Aegerion), a biopharmaceutical company dedicated to the development and commercialization of … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]
[at noodls] – CAMBRIDGE, Mass., Jan. 10, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) (Aegerion), a biopharmaceutical company dedicated to the development and commercialization of … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]
[at noodls] – CAMBRIDGE, Mass., Jan. 7, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]
[at noodls] – CAMBRIDGE, Mass., Jan. 4, 2013 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]
